Table 1.
The Clinical Information of Lung Cancer Patients From TCGA and GEO Databases.
| Database | TCGA | |
|---|---|---|
| Platform | Illumina HiSeq2000 RNA sequencing platform | |
| Histology types | LUAD | LUSC |
| Age | ||
| ≤60 years | 160 (30.7%) | 108 (21.4) |
| >60 years | 343 (65.7.0%) | 387 (76.8) |
| Unknow | 19 (3.6%) | 9 (1.8) |
| Gender | ||
| Male | 242 (46.4%) | 373 (74.0) |
| Female | 280 (53.6%) | 131 (26.0) |
| TNM stage | ||
| Stage I | 279 (53.4%) | 245 (48.6) |
| Stage II | 124 (23.8%) | 163 (32.3) |
| Stage III | 85 (16.3%) | 85 (16.9) |
| Stage IV | 26 (5.0%) | 7 (1.4) |
| Unknow | 8 (1.5%) | 4 (0.8) |
| T stage | ||
| T1 | 172 (33.0%) | 114 (22.6%) |
| T2 | 281 (53.8%) | 295 (58.5%) |
| T3 | 47 (9.0%) | 71 (14.1%) |
| T4 | 19 (3.6%) | 24 (4.8%) |
| TX | 3 (0.6%) | 0 (0.0%) |
| Unknow | 0 (0.0%) | 0 (0.0%) |
| N stage | ||
| N0 | 335 (64.2%) | 320 (63.5%) |
| N1-3 | 175 (33.5%) | 178 (35.3%) |
| NX | 11 (2.1%) | 6 (1.2%) |
| Unknow | 1 (0.2%) | 0 (0.0%) |
| M stage | ||
| M0 | 353 (67.6%) | 414 (82.1%) |
| M1 | 25 (4.8%) | 7 (1.4%) |
| MX | 140 (26.8%) | 79 (15.7%) |
| Unknow | 4 (0.8%) | 4 (0.8%) |
| Recurrence | ||
| Yes | 109 (20.9%) | 84 (16.7%) |
| No | 197 (37.7%) | 193 (38.3%) |
| Unknow | 216 (41.4%) | 227 (45.0%) |
| Survival status | ||
| Alive | 355 (68.0%) | 304 (60.3%) |
| Dead | 167 (32.0%) | 200 (39.7%) |
| Database | GEO (GSE3141) | |
| platform | Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) | |
| Histology types | LUAD | LUSC |
| Survival status | ||
| Alive | 26 (44.8%) | 27 (50.9%) |
| Dead | 32 (55.2%) | 26 (49.1%) |